BACKGROUND Coeliac disease is an autoimmune disorder triggered by ingesting gluten. It
affects approximately 1% of the UK population, but only one in three people is thought to …

Around the world, cancer care services are facing many operational challenges. Operations
management research can provide important solutions to these challenges, from screening …

With diverse aetiologies, treatment pathways and outcomes, haematological malignancies
comprise a heterogeneous group of over 60 cancers. 1, 2 Critically for epidemiology …

Background Few studies have estimated the real-world economic burden such as all-cause
and follicular lymphoma (FL)-related costs and health care resource utilization (HCRU) in …

While health care costs can be considerable in individuals with diffuse large B-cell
lymphoma (DLBCL), the degree to which health care expenditures vary following first-line …

Background In the past decades, highly innovative treatments in the field of diffuse large B-
cell lymphoma (DLBCL) became available in clinical practice. The aim of this study was to …

Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin
lymphoma and is a clinically heterogeneous disease. Treatment pathways for DLBCL are …

Background. Different strategies toward implementing competing risks in discrete-event
simulation (DES) models are available. This study aims to provide recommendations …

Objectives To use real-world data to develop a flexible generic decision model to predict
cost, life expectancy, and quality-adjusted life-years (QALYs) for follicular lymphoma (FL) in …

Purpose Diffuse large B‐cell lymphoma (DLBCL) is an aggressive lymphoma often
refractory to currently available treatments (immuno‐chemotherapy/autologous‐stem‐cell …